RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Clinical trials for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR t therapy targets tough lung cancer in first human trial
Disease control Recruiting nowThis study tests a new treatment called GC511B for adults with a type of lung cancer that has come back or stopped responding to other treatments. The therapy uses specially engineered immune cells (CAR T cells) to attack cancer cells that have a protein called DLL3. The main goa…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 11, 2026 12:08 UTC
-
New hope for tough lung cancer: experimental combo targets relapsed cases
Disease control Recruiting nowThis study tests an experimental drug (BMS-986525) alone or with another drug (nivolumab) in people whose small cell lung cancer has returned or stopped responding to standard chemotherapy. About 240 adults will take part to see if the treatment is safe and shrinks tumors. The go…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC